Greenbrook TMS (Greenbrook TMS) EBIT : $-41.90 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS EBIT?

Greenbrook TMS's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-10.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-41.90 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Greenbrook TMS's annualized ROC % for the quarter that ended in Mar. 2024 was -82.75%. Greenbrook TMS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -115.55%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Greenbrook TMS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -28.21%.

Greenbrook TMS EBIT Historical Data

The historical data trend for Greenbrook TMS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS EBIT Chart

Greenbrook TMS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-14.03

-27.60

-20.10

-82.33

-37.21

Greenbrook TMS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-7.97	-8.51	-8.76	-14.30	-10.34

Competitive Comparison of Greenbrook TMS's EBIT

For the Medical Care Facilities subindustry, Greenbrook TMS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenbrook TMS's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Greenbrook TMS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Greenbrook TMS's EV-to-EBIT falls into.

Greenbrook TMS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-41.90 Mil.

Greenbrook TMS (OTCPK:GBNHF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Greenbrook TMS's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-41.352 * ( 1 - 0% )	/	( (49.668	+	50.275)	/ 2 )
=	-41.352	/	49.9715
=	-82.75 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	51.418	-	19.431	-	( 3.324	-	max(0, 32.654	-	14.973	+	3.324	))
=	49.668

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	52.653	-	18.801	-	( 2.653	-	max(0, 32.718	-	16.295	+	2.653	))
=	50.275

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Greenbrook TMS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-41.352	/	( ( (35.822 + max(-10.083, 0))	+	(35.753 + max(-7.459, 0)) )	/	2 )
=	-41.352	/	( ( 35.822	+	35.753 )	/	2 )
=	-41.352	/	35.7875
=	-115.55 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(7.57	+	0	+	4.079)	-	(19.431	+	2.3	+	0.0010000000000048)
=	-10.083

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.534	+	0	+	5.108)	-	(18.801	+	2.3	+	7.105427357601E-15)
=	-7.459

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Greenbrook TMS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-41.899	/	148.526
	=	-28.21 %

Greenbrook TMS EBIT Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenbrook TMS (Greenbrook TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4

Website

https://www.greenbrooktms.com

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.